3 best performing ASX shares in the week of 1 August 2022

Marc Kennis Marc Kennis, August 8, 2022

Best performing ASX shares

The three best performing ASX shares in the week of 1 August 2022 were Plexure Group (ASX:PX1), up 97.1%, Resapp Health (ASX:RAP), up 65.2%, and Paradigm Biopharmaceuticals (ASX:PAR), up 52.2%.

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Plexure Group (ASX:PX1)

Industry: Software & IT Services

Plexure Group Limited (ASX:PX1) is a global mobile engagement company helping brands create sticky and more profitable relationships with consumers. Harnessing the power of consumer, contextual, behavioral and sales data, we enable the delivery of deeply personalized compelling offers to customers through mobile channels.

Market Cap: $118m

12 month high / low: $0.125 – $0.73

 

Plexure

 

 

2. Resapp Health (ASX:RAP)

Industry: Technology

ResApp Health Limited (ASX:RAP) is a digital health company developing smartphone applications for the diagnosis and management of respiratory disease. The technology is based on machine learning algorithms that use cough sounds to diagnose and measure the severity of respiratory conditions without the need for additional hardware.

Market Cap: $163M

12 month high / low: $0.042 – $0.1975

 

ResApp

 

 

3. Paradigm Biopharmaceuticals (ASX:PAR)

Industry: Healthcare

Paradigm Biopharmaceuticals Limited (ASX:PAR) wraps our 3 best performing ASX shares this week. PAR is involved in researching and developing therapeutic products for human use. It is a drug repurposing company, which seeks to find new uses for old drugs, thereby reducing the cost and time to bring therapeutics to market. 

Market Cap: $392m

12 month high / low: $0.855 – $2.69

 

Paradigm Biopharmaceuticals

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

dual class shares

Here’s what you need to know about dual class shares and why the ASX still bans them in 2025

If you want to invest in the world’s biggest tech companies, you need to know about Dual class shares. Even…

uber

Uber (NYSE:UBER): Finally mature and profitable, but with more growth to come

More than a decade and a half since it was founded, Uber (NYSE:UBER) is finally a mature company. It has…

Are CBA shares overvalued

Are CBA shares overvalued at $300bn? Here’s 4 arguments why they are, 4 reasons why they aren’t and our judgement

Are CBA shares overvalued? This has a hotly contested question for many months and particularly now that it is capped…